Annual SG&A
$10.62 M
+$2.32 M+27.97%
31 December 2023
Summary:
Forte Biosciences annual selling, general & administrative expenses is currently $10.62 million, with the most recent change of +$2.32 million (+27.97%) on 31 December 2023. During the last 3 years, it has risen by +$6.40 million (+151.69%). FBRX annual SG&A is now at all-time high.FBRX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.76 M
-$4.32 M-61.02%
30 September 2024
Summary:
Forte Biosciences quarterly selling, general & administrative expenses is currently $2.76 million, with the most recent change of -$4.32 million (-61.02%) on 30 September 2024. Over the past year, it has dropped by -$1.09 million (-28.28%). FBRX quarterly SG&A is now -61.02% below its all-time high of $7.08 million, reached on 30 June 2024.FBRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$529.75 M
-$34.20 M-6.90%
30 September 2024
Summary:
Forte Biosciences TTM selling, general & administrative expenses is currently -$529.75 million, with the most recent change of -$34.20 million (-6.90%) on 30 September 2024. Over the past year, it has dropped by -$540.01 million (-5262.79%). FBRX TTM SG&A is now -1167.93% below its all-time high of $17.19 million, reached on 30 June 2024.FBRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.0% | -28.3% | -5262.8% |
| 3 y3 years | +151.7% | +35.0% | -7505.0% |
| 5 y5 years | - | +733.5% | -10000.0% |
FBRX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +151.7% | -61.0% | +51.5% | -121.1% | at low |
| 5 y | 5 years | at high | +151.7% | -61.0% | +733.5% | -1167.9% | at low |
| alltime | all time | at high | +151.7% | -61.0% | +764.9% | -1167.9% | at low |
Forte Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.76 M(-61.0%) | $16.10 M(-6.3%) |
| June 2024 | - | $7.08 M(+105.1%) | $17.19 M(+43.2%) |
| Mar 2024 | - | $3.45 M(+22.6%) | $12.01 M(+13.0%) |
| Dec 2023 | $10.62 M(+28.0%) | $2.81 M(-26.9%) | $10.62 M(+3.5%) |
| Sept 2023 | - | $3.85 M(+103.0%) | $10.26 M(+21.3%) |
| June 2023 | - | $1.90 M(-8.4%) | $8.46 M(-1.1%) |
| Mar 2023 | - | $2.07 M(-15.6%) | $8.55 M(+3.0%) |
| Dec 2022 | $8.30 M | $2.45 M(+19.9%) | $8.30 M(+6.5%) |
| Sept 2022 | - | $2.04 M(+2.9%) | $7.80 M(+0.0%) |
| June 2022 | - | $1.99 M(+9.1%) | $7.80 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.82 M(-6.5%) | $8.04 M(+5.3%) |
| Dec 2021 | $7.63 M(+80.8%) | $1.95 M(-4.7%) | $7.63 M(+6.7%) |
| Sept 2021 | - | $2.04 M(-8.1%) | $7.15 M(+11.2%) |
| June 2021 | - | $2.22 M(+56.7%) | $6.43 M(+29.5%) |
| Mar 2021 | - | $1.42 M(-3.3%) | $4.97 M(+17.7%) |
| Dec 2020 | $4.22 M | $1.47 M(+11.2%) | $4.22 M(+53.3%) |
| Sept 2020 | - | $1.32 M(+73.7%) | $2.75 M(+56.1%) |
| June 2020 | - | $760.00 K(+12.9%) | $1.76 M(+33.3%) |
| Mar 2020 | - | $673.00 K(+103.3%) | $1.32 M(+103.5%) |
| Sept 2019 | - | $331.00 K(+3.8%) | $650.00 K(+103.8%) |
| June 2019 | - | $319.00 K | $319.00 K |
FAQ
- What is Forte Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Forte Biosciences?
- What is Forte Biosciences annual SG&A year-on-year change?
- What is Forte Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Forte Biosciences?
- What is Forte Biosciences quarterly SG&A year-on-year change?
- What is Forte Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Forte Biosciences?
- What is Forte Biosciences TTM SG&A year-on-year change?
What is Forte Biosciences annual selling, general & administrative expenses?
The current annual SG&A of FBRX is $10.62 M
What is the all time high annual SG&A for Forte Biosciences?
Forte Biosciences all-time high annual selling, general & administrative expenses is $10.62 M
What is Forte Biosciences annual SG&A year-on-year change?
Over the past year, FBRX annual selling, general & administrative expenses has changed by +$2.32 M (+27.97%)
What is Forte Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of FBRX is $2.76 M
What is the all time high quarterly SG&A for Forte Biosciences?
Forte Biosciences all-time high quarterly selling, general & administrative expenses is $7.08 M
What is Forte Biosciences quarterly SG&A year-on-year change?
Over the past year, FBRX quarterly selling, general & administrative expenses has changed by -$1.09 M (-28.28%)
What is Forte Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of FBRX is -$529.75 M
What is the all time high TTM SG&A for Forte Biosciences?
Forte Biosciences all-time high TTM selling, general & administrative expenses is $17.19 M
What is Forte Biosciences TTM SG&A year-on-year change?
Over the past year, FBRX TTM selling, general & administrative expenses has changed by -$540.01 M (-5262.79%)